Delivery Order SPE2DB20D3505-SPE2DB23FU4G7
Award Date 7/19/23
Potential Completion Date 7/20/23
Potential Value $773
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,355.10 delivery order to Amerisourcebergen Drug Corporation for the supply of 150 mg Orilissa tablets. Under this firm fixed price contract, Amerisourcebergen will deliver seven bottles of the prescription drug to a facility in Conshohocken, Pennsylvania by July 3, 2023 to support the DLA's medical supply needs. As a top pharmaceutical distributor, Amerisourcebergen routinely fulfills delivery orders under the DLA's Prime Vendor program on behalf of...
- The Defense Logistics Agency awarded a $3,779.34 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for 14 tablets of the 200mg Orilissa drug. The order is for product delivery to a location in Conshohocken, Pennsylvania by October 12, 2023. No set-aside designation was applied to this order, which is being fulfilled under the parent company Amerisourcebergen's corporate office. The Defense Logistics Agency functions include procuring...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $678 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will deliver 150mg tablets of Orilissa to a facility in Conshohocken, Pennsylvania, with performance spanning July 19-20, 2023. As a major supplier of pharmaceuticals and medical goods, Amerisourcebergen will support the Defense Logistics Agency in providing this medication to DOD personnel and affiliates. No...
- The Defense Logistics Agency awarded a $2,491.20 delivery order to AmerisourceBergen Drug Corp for Orilissa 150 mg tablets (7-count package) under a firm fixed price contract type. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-competitive delivery order supporting the federal government's pharmaceutical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a $2,321.58 delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity: 7 units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Orilissa 150 mg tablets (seven-count packages) under a firm fixed-price contract valued at $4,756.11, with completion scheduled for September 8, 2025. This non-set-aside competitive award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Orilissa 200 mg tablets (14-count packaging) with a ceiling value of $8,559.49 under a firm fixed-price contract. This non-set-aside award was competitively procured and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $68,576.46 delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (seven-count units) under a firm fixed price contract. The contract was competitively awarded with no set-aside designation and includes an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency Troop Support Medical awarded a $3,109.12 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 14 tablets of Orilissa 200 mg to be delivered to their Conshohocken, Pennsylvania facility. The delivery order was issued on July 25, 2023 under an existing Prime Vendor contract vehicle and has a period of performance through July 26, 2023. No set aside designation or subcontracting requirements were specified. This supports DLA's medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,205.70 to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity 7) on April 29, 2025, with completion scheduled for April 30, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Orilissa is a prescription medication used in women's healthcare, reflecting the broad...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FU4G7Delivery Order
The Defense Logistics Agency awarded a $772.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 14 tablets of Orilissa 200 mg to be delivered to a location in Conshohocken, Pennsylvania between July 19-20, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order for the prescription drug under the DLA's prime vendor contract vehicle. No set aside designation or subcontractors were identified. The brief period of performance and low dollar value suggest this delivery order is for routine medical stock rather than a major new program initiative.
Generated 12/24/23, 3:29 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $773 | 7/19/23 |